ID   WEHI-3B
AC   CVCL_2239
SY   WEHI-3b; Wehi-3B; WEHI 3B; WEHI3B; W3(H); WEHI-3 subline B
DR   BTO; BTO_0005282
DR   CLO; CLO_0009569
DR   CLO; CLO_0009580
DR   CLO; CLO_0050196
DR   CLDB; cl4684
DR   CLDB; cl4685
DR   CLDB; cl4686
DR   CLDB; cl4937
DR   BCRJ; 0248
DR   ChEMBL-Cells; CHEMBL3307352
DR   ChEMBL-Targets; CHEMBL614249
DR   CLS; 400376
DR   DSMZ; ACC-26
DR   DSMZCellDive; ACC-26
DR   ECACC; 86013003
DR   IBRC; C10075
DR   ICLC; ATL99003
DR   JCRB; IFO50296
DR   Lonza; 1430
DR   PubChem_Cell_line; CVCL_2239
DR   RCB; RCB2853
DR   TKG; TKG 0584
DR   Wikidata; Q54993761
RX   DOI=10.1016/0165-4608(80)90043-6;
RX   PubMed=3792703;
RX   PubMed=5259325;
RX   PubMed=8343448;
RX   PubMed=17635523;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=WEHI-3B
CC   Characteristics: Constitutively produces interleukin-3 (IL3).
CC   Doubling time: 20 hours (PubMed=8343448); ~20-30 hours (DSMZ=ACC-26).
CC   Transformant: DrugBank; DB11057; Mineral oil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: BALB/c.
ST   Source(s): DSMZ=ACC-26
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 18,19,20
ST   Mouse STR 6-7: 12
ST   Mouse STR 12-1: 16,17
ST   Mouse STR 15-3: 22.3,23.3,25.3
ST   Mouse STR 18-3: 18
ST   Mouse STR X-1: 25,26
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3622 ! WEHI-3
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
CH   CVCL_4357 ! WEHI-3B D+
CH   CVCL_WB18 ! WEHI-3B*
CH   CVCL_WW74 ! WEHI-3B-Y1
//
RX   DOI=10.1016/0165-4608(80)90043-6;
RA   Bornstein, Sandra
RA   McMorrow, Lydia E.
RT   "Marker chromosomes of WEHI-3, a murine myelomonocytic cell line.";
RL   Cancer Genet. Cytogenet. 1:345-349(1981).
//
RX   PubMed=3792703; DOI=10.1111/j.1432-0436.1986.tb00568.x;
RA   Leenen, Pieter J.M.
RA   Jansen, Anita M.A.C.
RA   van Ewijk, Willem
RT   "Murine macrophage cell lines can be ordered in a linear
RT   differentiation sequence.";
RL   Differentiation 32:157-164(1986).
//
RX   PubMed=5259325; DOI=10.1093/jnci/43.4.963;
RA   Warner, Noel L.
RA   Moore, Malcolm A.S.
RA   Metcalf, Donald
RT   "A transplantable myelomonocytic leukemia in BALB-c mice: cytology,
RT   karyotype, and muramidase content.";
RL   J. Natl. Cancer Inst. 43:963-982(1969).
//
RX   PubMed=8343448;
RA   Kajigaya, Yasuhiko
RA   Sasaki, Hideki
RA   Ikuta, Koichiro
RA   Matsuyama, Shusuke
RA   Hirabayashi, Yoko
RA   Inoue, Tohru
RT   "Serum-free culture for leukemia cells.";
RL   Hum. Cell 6:49-56(1993).
//
RX   PubMed=17635523; DOI=10.1111/j.1365-2184.2007.00456.x; PMCID=PMC6495790;
RA   Pessina, Augusto
RA   Bonomi, Arianna
RA   Casati, Silvia
RA   Collotta, Angelo
RA   Croera, Cristina
RA   Marafante, Erminio
RA   Palitti, Fabrizio
RA   Gribaldo, Laura
RT   "Mitochondrial function, apoptosis and cell cycle delay in the WEHI-3B
RT   leukaemia cell line and its variant Ciprofloxacin-resistant
RT   WEHI-3B/CPX.";
RL   Cell Prolif. 40:568-579(2007).
//